91 related articles for article (PubMed ID: 15464623)
1. Synthesis and GABA uptake inhibitory properties of 6-aryl iminoxymethyl substituted nipecotic acids.
N'goka V; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G
Eur J Med Chem; 2004 Oct; 39(10):889-95. PubMed ID: 15464623
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and GABA uptake properties of 6-ether- and 6-enol ether-substituted nipecotic acids.
N'Goka V; Bissantz C; Bisel P; Stenbøl TB; Krogsgaard-Larsen P; Schlewer G
Eur J Med Chem; 2004 Jul; 39(7):633-8. PubMed ID: 15236844
[TBL] [Abstract][Full Text] [Related]
3. GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-substituents.
Falch E; Krogsgaard-Larsen P
Drug Des Deliv; 1989 May; 4(3):205-15. PubMed ID: 2535204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
Quandt G; Höfner G; Wanner KT
Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
Tóth K; Höfner G; Wanner KT
Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a trans-alkene spacer as potent GABA uptake inhibitors.
Tóth K; Höfner G; Wanner KT
Bioorg Med Chem; 2018 Dec; 26(22):5944-5961. PubMed ID: 30442505
[TBL] [Abstract][Full Text] [Related]
7. Uptake and release of nipecotic acid by rat brain slices.
Johnston GA; Stephanson AL; Twitchin B
J Neurochem; 1976 Jan; 26(1):83-7. PubMed ID: 1255185
[No Abstract] [Full Text] [Related]
8. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 4-substituted nipecotic acid derivatives and their evaluation as potential GABA uptake inhibitors.
Hellenbrand T; Höfner G; Wein T; Wanner KT
Bioorg Med Chem; 2016 May; 24(9):2072-96. PubMed ID: 27039250
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M
Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748
[TBL] [Abstract][Full Text] [Related]
11. Uptake of GABA and nipecotic acid in astrocytes and neurons in primary cultures: changes in the sodium coupling ratio during differentiation.
Larsson OM; Hertz L; Schousboe A
J Neurosci Res; 1986; 16(4):699-708. PubMed ID: 3025461
[TBL] [Abstract][Full Text] [Related]
12. Functional GABA uptake at inhibitory synapses in CA1 of chronically epileptic rats.
Stief F; Piechotta A; Gabriel S; Schmitz D; Draguhn A
Epilepsy Res; 2005; 66(1-3):199-202. PubMed ID: 16154723
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.
Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake.
Pavia MR; Lobbestael SJ; Nugiel D; Mayhugh DR; Gregor VE; Taylor CP; Schwarz RD; Brahce L; Vartanian MG
J Med Chem; 1992 Oct; 35(22):4238-48. PubMed ID: 1433224
[TBL] [Abstract][Full Text] [Related]
15. Nipecotic acid: preferential accumulation in the cochlea by GABA uptake systems and selective retrograde transport to brainstem.
Ryan AF; Schwartz IR
Brain Res; 1986 Dec; 399(2):399-403. PubMed ID: 3828775
[TBL] [Abstract][Full Text] [Related]
16. Comparison between (RS)-nipecotic acid and GABA transport in cultured astrocytes: coupling with two sodium ions.
Larsson OM; Schousboe A
Neurochem Res; 1981 Mar; 6(3):257-66. PubMed ID: 7279105
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.
Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD
J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872
[TBL] [Abstract][Full Text] [Related]
18. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
Lutz T; Wein T; Höfner G; Wanner KT
ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
[TBL] [Abstract][Full Text] [Related]
19. Entropy as a factor in the binding of gamma-aminobutyric acid and nipecotic acid to the gamma-aminobutyric acid transport system.
Althaus JS; Martin DL
Neurochem Res; 1989 Apr; 14(4):311-6. PubMed ID: 2548104
[TBL] [Abstract][Full Text] [Related]
20. High-affinity uptake of (RS)-nipecotic acid in astrocytes cultured from mouse brain. Comparison with GABA transport.
Larsson OM; Krogsgaard-Larsen P; Schousboe A
J Neurochem; 1980 Apr; 34(4):970-7. PubMed ID: 7359143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
